Indranil Chatterjee et al.
COMMUNICATIONS
References
compounds are feasible. Work along this line is under
way. DFT calculations give strong indications that re-
actions occur via a concerted asynchronous [2+2]cy-
cloaddition pathway.
[1] Reviews: a) H. Waldmann, Synthesis 1994, 535–551;
b) J. Streith, A. Defoin, Synthesis 1994, 1107–1117;
c) P. F. Vogt, M. Miller, Tetrahedron 1998, 54, 1317–
1348; d) H. Yamamoto, N. Momiyama, Chem.
Commun. 2005, 3514–3525; e) Y. Yamamoto, H. Ya-
mamoto, Eur. J. Org. Chem. 2006, 2031–2043; f) H. Ya-
mamoto, M. Kawasaki, Bull. Chem. Soc. Jpn. 2007, 80,
595–607.
Experimental Section
General Procedure for the Enantioselective
[2+2]Cycloaddition Reaction with (R,P)-Walphos
(GP1)
[2] H. Staudinger, S. Jelagin, Ber. dtsch. chem. Ges. 1911,
44, 365–374.
[3] a) G. Kresze, A. Trede, Tetrahedron 1963, 19, 133–136;
b) R. C. Kerber, M. C. Cann, J. Org. Chem. 1974, 39,
2552–2558; c) D. Moderhack, K. Stolz, Chem.-Ztg.
1990, 114, 5–7.
[4] M. W. Barker, J. T. Gill, J. Heterocycl. Chem. 1970, 7,
1203–1204; M. W. Barker, L. Combs, J. T. Gill, J. Het-
erocycl. Chem. 1972, 9, 77–79.
ACHTUNGTRENNUNG(R,P)-Walphos ligand (10 mol%) and [Cu(I)ACHTUNGTRNE(NGUN CH3CN)4]PF6
(10 mol%) were added to a flame dried Schlenk tube under
an argon atmosphere. The catalyst was dried at room tem-
perature for 10 min under vacuum. The Schlenk tube was
recharged with argon and anhydrous CH2Cl2 (~12 mM with
respect to ligand) was added to the mixture and the result-
ing solution was stirred under argon for 1 h at room temper-
ature. The solution was then cooled to À708C, a solution of
2-nitrosopyridine (1.0 equiv.) in CH2Cl2 (~15 mM) was
added dropwise over 10 min and the resulting dark blue so-
lution was stirred for 15 min. A solution of the ketene in
CH2Cl2 (~12 mM) was added slowly over 3.5 h at À708C.
After completion of addition the mixture was slowly
warmed to À508C and was stirred for 12 h at that tempera-
ture. The solvent was removed under reduced pressure and
the crude product was subjected to silica gel chromatogra-
phy to afford the isomeric adducts.
[5] R. W. Hoffmann, H. Hꢀuser, Angew. Chem. 1964, 76,
346.
[6] M. Dochnahl, G. C. Fu, Angew. Chem. 2009, 121, 2427–
2429; Angew. Chem. Int. Ed. 2009, 48, 2391–2393.
[7] a) C. K. Jana, A. Studer, Angew. Chem. 2007, 119,
6662–6664; Angew. Chem. Int. Ed. 2007, 46, 6542–
6544; b) C. K. Jana, A. Studer, Chem. Eur. J. 2008, 14,
6326–6328; c) C. J. Jana, S. Grimme, A. Studer, Chem.
Eur. J. 2009, 15, 9078–9084.
[8] a) Y. Yamamoto, H. Yamamoto, J. Am. Chem. Soc.
2004, 126, 4128–4129; b) Y. Yamamoto, H. Yamamoto,
Angew. Chem. 2005, 117, 7244–7247; Angew. Chem.
Int. Ed. 2005, 44, 7082–7085.
4-Ethyl-4-phenyl-2-pyridin-2-yl-1,2-oxazetidin-3-one (1a):
According to GP1: (R,P)-Walphos (12.9 mg, 0.014 mmol),
[Cu(I)
(CH3CN)4]PF6
(5.17 mg,
0.014 mmol),
CH2Cl2
(2.0 mL), 2-nitrosopyridine (15 mg, 0.14 mmol) in CH2Cl2
(0.5 mL), phenyl ethyl ketene (28 mg, 0.18 mmol) in CH2Cl2
(1.0 mL) and SiO2 chromatography (pentane/MTBE, 4:1)
gave 1a as brownish yellow oil; yield: 28.2 mg (80%). TLC:
Rf =0.5 (pentane/MTBE, 2:1); [a]2D5: +84.36 (c 0.78, CHCl3);
[9] The regioisomer which was identified by TLC was
formed in small amounts, however, due to decomposi-
tion during purification, quantification was not possi-
ble.
[10] a) A. Miyashita, A. Yasuda, H. Takaya, K. Toriumi, T.
Ito, T. Souchi, R. Noyori, J. Am. Chem. Soc. 1980, 102,
7932–7934; b) S. Jeulin, S. D. de Paule, V. Ratoveloma-
nana-Vidal, J.-P. GenÞt, N. Champion, P. Dellis, Angew.
Chem. 2004, 116, 324–329; Angew. Chem. Int. Ed.
2004, 43, 320–325; c) T. Saito, T. Yokozawa, T. Ishizaki,
T. Moroi, N. Sayo, T. Miura, H. Kumobayashi, Adv.
Synth. Catal. 2001, 343, 264–267; d) B. Pugin, P.
Martin, M. Mueller, F. Naud, F. Spindler, M. Thom-
men, G. Melone, M. Kesselgruber, Patent WO
2004089920, 2004; e) T. Sturm, W. Weissensteiner, F.
Spindler, Adv. Synth. Catal. 2003, 345, 160–164.
[11] Enantiomeric ratio was determined by HPLC by using
chiral colums (for details, see the Supporting Informa-
tion) and the absolute configuration of the major
isomer was assigned by transformation of 1a into a
known compound as will be discussed below.
˜
FT-IR (film): n=3057, 2979, 2939, 1730, 1651, 1582, 1448,
1
1398, 1263, 976, 930, 882, 731, 699 cmÀ1; H NMR (300 MHz,
CDCl3): d=8.34 (d, J=4.5 Hz, 1H) , 7.65–7.59 (m, 1H),
7.51–7.48 (m, 2H), 7.37–7.28 (m, 3H), 7.20 (d, J=8.2 Hz,
1H), 7.0–6.96 (m, 1H), 2.33–2.17 (m, 2H), 1.03 (t, J=
7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3): d=164.6, 148.9,
148.6, 138.0, 135.4, 128.1, 128.7, 124.8, 120.1, 109.85, 102.5,
29.9, 7.7; HR-MS (ESI): m/z=277.0946, exact mass calculat-
ed for C15H14N2O2Na ([M+Na]+): 277.0947. The enantio-
meric ratio (97:03) was determined by chiral HPLC
(column: Chiralcel IA; solvent: cyclohexane:2-propanol
(99:01); flow: 1.0 mLminÀ1): minor enantiomer tr =
12.206 min, major enantiomer tr =14.359 min.
Supporting Information
Further experimental procedures and compound characteri-
zation data are available as Supporting Information.
[12] C. Agami, F. Couty, C. Lequesne, Tetrahedron 1995, 51,
4043–4056.
[13] a) S. Grimme, J. Comput. Chem. 2006, 27, 1787–1799;
b) S. Grimme, J. Chem. Phys. 2006, 124, 034108; c) T.
Schwabe, S. Grimme, Phys. Chem. Chem. Phys. 2007, 9,
3397–3406; d) A. Schꢀfer, C. Huber, R. Ahlrichs, J.
Chem. Phys. 1994, 100, 5829–5835; e) F. Weigend, R.
Ahlrichs, Phys. Chem. Chem. Phys. 2005, 7, 3297–3305.
Acknowledgements
We thank the DFG for supporting our work. Solvias AG is
acknowledged for donation of various chiral ligands.
948
ꢂ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2010, 352, 945 – 948